IL-15 is thought to be involved in the pathogenesis of rheumatoid arthritis (RA). We found that IL-15 plays an important role in the development of murine collagen-induced arthritis (CIA). The incidence and severity of CIA were slightly decreased in IL-15 KO mice but were increased in IL-15 Tg mice compared with wild-type (WT) mice. The levels of type II collagen (CII)-specific IL-17 production were significantly increased in IL-15 Tg mice compared with WT mice with CIA. Expression of IL-23R was up-regulated in CD4 + T cells in IL-15 Tg mice but down-regulated in IL-15 KO mice compared with WT mice. In correlation with the expression levels of IL-23R, IL-17 production by CD4 + T cells in response to exogenous IL-23 was increased in IL-15 Tg mice compared with WT mice. Furthermore, exogenous IL-15 synergized with IL-23 to induce CII-specific IL-17 production by CD4 + T cells in vitro. Taken together, these results indicate that IL-15 plays an important role in the progression of CIA through increasing antigen-specific IL-17 production by CD4 + T cells.
IntroductionRheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of synovial tissues in multiple joints, which results in destruction of bone and cartilage. Pro-inflammatory cytokines play important roles in this process, as evidenced by the clinical success of cytokine blockade therapies [1,2]. Similar to human RA, various pro-inflammatory cytokines including TNF-a and IL-1b are involved in the pathogenesis of collagen-induced arthritis (CIA), a rodent model of human RA [3][4][5]. The development of CIA depends on both cellular and humoral immune responses to type II collagen (CII) that activate inflammatory cytokine cascades [3,6]. The Th1 response was believed to be essential for the development of the disease [3]. However, recent studies have indicated a critical role of IL-17 in the pathogenesis of autoimmune disease models such as CIA [7,8].IL-17 is a pro-inflammatory cytokine produced mainly by memory CD4 + T cells that stimulates synoviocytes or macrophages to induce various cytokines such as TNF-a and IL-1 [9][10][11]. Lubberts et al. [7] have demonstrated that treatment of DBA1 mice with neutralizing anti-IL-17 Ab shortly after the onset suppressed the development of the CIA, suggesting a critical role of IL-17 at the effector phase. In addition, Nakae et al. [8] have reported, using IL-17-deficient mice with C57BL/6 Â 129 background, that IL-17 was also involved in CIA at the induction phase. IL-17 expression is strongly induced in memory T cells by IL-23, a member of the IL-12 family of cytokines, via signaling through its receptor composed of . Recently, it was demonstrated that IL-23 but not IL-12 is indispensable for the development of CIA, indicating that an IL-17-producing CD4 + T cell response, but not the "classical" Th1 response, is essential for the disease [13,14]. IL-15, a member of the four-helix bundle cytokine family, stimulates macrophages/dendritic cells, natural killer (NK) cells, NKT cells, mucosal...